IP Group (IPO)
IPO Share PerformanceMore
|52 week high||158.45 24/02/17|
|52 week low||107.20 19/02/18|
|52 week change||-41.05 (-26.37%)|
|4 week volume||16,948,954 30/01/18|
Latest News« previous» nextMore
17/01/2018 - 11:53 RNS
RNS Number: 1513C Ilika plc 17 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Ilika plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. R...
10/01/2018 - 09:12 RNS
RNS Number: 4733B IP Group PLC 10 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: IP Group PLC 1b. Please...
02/01/2018 - 07:00 RNS
RNS Number: 6366A IP Group PLC 02 January 2018 FOR RELEASE ON 02 January 2018 IP Group plc - Voting Rights and Capital - Month End Disclosure Pursuant to Disclosure and Transparency Rule 5.6: As at the date of this announcement the issued share capital of IP Group plc comprised 1,057,383,601 ordinary shares of 2p each. There were no shares held in trea...
18/12/2017 - 10:15 RNS
RNS Number: 6292Z IP Group PLC 18 December 2017 FOR RELEASE ON 18 December 2017 THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO.596/2014. IP Group plc - Portfolio company Autifony Therapeutics signs 627.5 million collaboration agreement with Boehrin...
15/12/2017 - 13:18 StockMarketWire
IP Group said it has noted that Diurnal Group confirmed the Committee for Medicinal Products for Human Use (CHMP)...
15/12/2017 - 12:50 RNS
RNS Number: 5297Z IP Group PLC 15 December 2017 FOR RELEASE ON 15 December 2017 IP Group plc - Portfolio company Diurnal receives positive CHMP opinion for Alkindi (Infacort ) for the treatment of paediatric adrenal insufficiency in Europe IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, is ...
15/12/2017 - 08:41 StockMarketWire
IP Group has announced that non-executive Doug Liversidge would retire from the board at the end of the year. Liversidg...
14/12/2017 - 16:48 RNS
RNS Number: 4224Z IP Group PLC 14 December 2017 FOR RELEASE ON 14 December 2017 IP Group plc - Retirement of Non-executive Director IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), a leading developer of intellectual property-based businesses, announces that Doug Liversidge, CBE, will retire from his position as a non-executive...
|Dividend yield||0 %|
Latest discussion posts More
“Thanks for your info Carefully . Dont sound to good gone but not clear where it gone. lol Not sure they can just move it a valuable asset .”▼
“IPO was in WPCT but no longer is. Don't know where it was moved to (which fund) or whether sold down. Woodford was pro IPO, IVO merger so held it back then. ”▼
“Little confused here, hope someone can explain. Winifrith blog posted all the holdings in Woodfords three funds. Surprised i did not see IPO. Then i see on another site ...”▼
Codes & Symbols
|Symbols||IPO, LSE:IPO, IPO.L, IPO:LN, LON:IPO, XLON:IPO|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment